Adaptive Biotechnologies Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Commercial Services » Miscellaneous Commercial Services
FLTFleetCor Technologies, Inc. 0.39%310.183.4%$268.50m
CPRTCopart, Inc. -0.24%96.984.5%$169.07m
JCIJohnson Controls International Plc -0.02%41.031.4%$149.27m
ETSYEtsy, Inc. 0.83%51.328.0%$123.03m
LOPEGrand Canyon Education, Inc. 1.35%97.472.0%$92.89m
EFXEquifax, Inc. 0.85%152.312.0%$84.26m
ITGartner, Inc. 0.02%160.952.4%$73.72m
TRUTransUnion 0.26%92.800.9%$72.53m
PRAHPRA Health Sciences, Inc. -0.24%106.032.5%$65.09m
BAHBooz Allen Hamilton Holding Corp. 0.25%79.192.0%$59.21m
PAGSPagSeguro Digital Ltd. -1.37%35.690.0%$59.15m
CDAYCeridian HCM Holding, Inc. -0.07%72.770.0%$54.32m
BRBroadridge Financial Solutions, Inc. 1.10%130.771.5%$52.28m
BFAMBright Horizons Family Solutions, Inc. -0.30%162.201.4%$39.25m
CHGGChegg, Inc. 1.24%43.2515.7%$38.07m

Company Profile

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.